Posted on 12/02/2021 12:48:14 PM PST by Mount Athos
The chairman and former Chief Executive Officer (CEO) of the Reuters news agency – James C. Smith – is a top investor and board member for pharmaceuticals giant Pfizer. He was elected to the board in 2014, as well as joining Pfizer’s Corporate Governance and Science and Technology Committees. The news raises serious conflict of interest concerns as corporate media outlets such as Reuters continue to promote Pfizer products, defend pharmaceuticals companies from criticism, and move to silence skeptics.
Smith is currently the Chairman of the Thomson Reuters Foundation, the London-based charity known for providing news and information to billions of readers. He was also the President, Chief Executive Officer, and on the Board of Director of Reuters from 2012 until his retirement in 2020.
He has worked with the organization since 1987, when they were known as the Thomson Newspaper group. He has also served as the CEO of the professional division, overseeing legal, tax and accounting, and intellectual property and science businesses. Later, he went on to lead the North America operations for the news organization.
In an official statement at the time, Ian Read, Pfizer’s chairman and CEO said: “We are pleased to have Jim Smith join Pfizer’s Board of Directors. He brings leadership and operational and international business experience to Pfizer’s Board, and will be an excellent asset to the company. The addition of Jim to our Board helps ensure that Pfizer will continue to benefit from a breadth and variety of experience.”
In the last year alone, Reuters has published more than 22,000 articles mentioning Pfizer. The company has only published 8,191 articles related to Moderna, and 18,000 related to Johnson & Johnson. Many of the articles about Johnson & Johnson were negative in sentiment, unlike their Pfizer reporting.
Smith is also linked to the World Economic Forum (WEF), where he serves on the board of Partnering Against Corruption Initiative. He’s also a member of WEF’s International Business Advisory Boards of British American Business and the Atlantic Council.
According to the Wall Street Journal, Smith also holds the position of President & CEO of Refinitiv Transaction Services, Ltd, who boasted $6.25 billion in revenue with more than 40,000 customers and 400,000 end users across 190 countries. Refinitiv was a member of the Thomson Reuters Group until 2018.
Thick as thieves
He was elected to the board in 2014, as well as joining Pfizer’s Corporate Governance and Science and Technology Committees.
—
It’s all very incestuous with the elitists. There is a revolving door between Big Pharma and the Fed agencies which are supposed to regulate them.
Advertising by Big Pharma permeates all the Networks and streaming sites like YouTube.
The Big Pharma ads you see like “Ask your doctor about Ymexlfexit” are nothing more than hush money. The ads don’t even bother to say what the drug is for. It’s all so freaking blatant.
he KNOWINGLY let innocents die because they
removed the incriminating Evidence that fewer
died in the controls.
then, he KNOWINGLY BROADCAST the songs to incite
millions to his crematoria-for-profit.
seems like a hanging offense.
Pfizer is the medicinal face of the CCP. 70 CCP members are on PFizer’s Investments Boards. Pfizer is China’s ‘stalking horse’.
That’s why Pfizer’s contracts are so draconian - demanding silence from officials, including loss of sovereign assets like military bases if a country violates the contract. It’s medical coup.
Incestuous.
.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.